{"latest_checked": "2026-09-23T03:32:18.826134+00:00", "coverage_count": 5044, "recent_count": 13, "transaction_limit": 160, "filters": {"q": "", "ticker": "INCY", "sector": "", "industry": "", "side": "", "start": "2026-08-09", "end": "2026-09-23"}, "summary": {"total": 13, "acquisition_count": 4, "disposal_count": 9, "acquisition_value": 1541331.44, "acquisition_value_label": "$1.5M", "disposal_value": 5515973.71, "disposal_value_label": "$5.5M", "net_value": -3974642.27, "net_value_label": "$-4.0M", "flow_tone": "negative", "largest_value_label": "$1.7M", "top_sector": "Healthcare", "window_label": "09 Aug 2026 to 23 Sep 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 13, "value": "7057305.1500", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$7.1M"}], "days": [{"transaction_date": "2026-08-12", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 10.0}, {"transaction_date": "2026-08-19", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 10.0}, {"transaction_date": "2026-08-25", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 10.0}, {"transaction_date": "2026-09-15", "acquisitions": 4, "disposals": 6, "total": 10, "bar_width": 100.0}], "side_mix": {"acquisitions": 4, "disposals": 9, "acquisition_share": 30.8, "disposal_share": 69.2}}, "company_flows": [{"symbol": "INCY", "name": "Incyte Corporation", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-09-15", "acquisitions": 4, "disposals": 5, "acquired_value": 1541331.44, "acquired_value_label": "$1.5M", "disposed_value": 5515973.71, "disposed_value_label": "$5.5M", "net_value": -3974642.27, "net_value_label": "$-4.0M", "acquisition_share": 44.4, "disposal_share": 55.6, "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}], "company_overview": [{"symbol": "INCY", "name": "Incyte Corporation", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-09-15", "filings": 13, "acquisitions": 4, "disposals": 9, "acquired_value": 1541331.44, "acquired_value_label": "$1.5M", "disposed_value": 5515973.71, "disposed_value_label": "$5.5M", "net_value": -3974642.27, "net_value_label": "$-4.0M", "acquisition_share": 30.8, "disposal_share": 69.2, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}], "transactions": [{"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-15", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Employee Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 6477.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-09-22T03:45:16.025201+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-15", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Employee Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 9233.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-09-22T03:45:16.017346+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-15", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Employee Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 2957.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-09-22T03:45:16.020338+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-15", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Employee Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 4551.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-09-22T03:45:16.022776+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-15", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 13985.0, "share_price": 120.49, "transaction_value": 1685052.65, "transaction_value_label": "$1.7M", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-09-22T03:45:16.031965+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-15", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 9233.0, "share_price": 120.5, "transaction_value": 1112576.5, "transaction_value_label": "$1.1M", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-09-22T03:45:16.029918+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-15", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 9233.0, "share_price": 71.93, "transaction_value": 664129.69, "transaction_value_label": "$664.1K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-09-22T03:45:16.027594+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-15", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 6477.0, "share_price": 64.25, "transaction_value": 416147.25, "transaction_value_label": "$416.1K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-09-22T03:45:16.037923+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-15", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 4551.0, "share_price": 61.18, "transaction_value": 278430.18, "transaction_value_label": "$278.4K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-09-22T03:45:16.035949+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-15", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 2957.0, "share_price": 61.76, "transaction_value": 182624.32, "transaction_value_label": "$182.6K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-09-22T03:45:16.033853+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-25", "executive": "BASI, RAMITPAL K", "executive_title": "EVP, Human Resources", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 504.0, "share_price": 129.72, "transaction_value": 65378.88, "transaction_value_label": "$65.4K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-09-15T04:12:44.892219+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-19", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 10801.0, "share_price": 125.56, "transaction_value": 1356173.56, "transaction_value_label": "$1.4M", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-09-09T03:10:18.082168+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-12", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 10803.0, "share_price": 120.04, "transaction_value": 1296792.12, "transaction_value_label": "$1.3M", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-08-31T04:56:49.751896+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}